ID   HDAC5_MOUSE             Reviewed;        1113 AA.
AC   Q9Z2V6; Q9JL73;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 2.
DT   04-FEB-2015, entry version 125.
DE   RecName: Full=Histone deacetylase 5;
DE            Short=HD5;
DE            EC=3.5.1.98;
DE   AltName: Full=Histone deacetylase mHDA1;
GN   Name=Hdac5;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Fetus;
RX   PubMed=9891014; DOI=10.1074/jbc.274.4.2440;
RA   Verdel A., Khochbin S.;
RT   "Identification of a new family of higher eukaryotic histone
RT   deacetylases. Coordinate expression of differentiation-dependent
RT   chromatin modifiers.";
RL   J. Biol. Chem. 274:2440-2445(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH NCOR2.
RC   STRAIN=C57BL/6;
RX   PubMed=10640276;
RA   Kao H.-Y., Downes M., Ordentlich P., Evans R.M.;
RT   "Isolation of a novel histone deacetylase reveals that class I and
RT   class II deacetylases promote SMRT-mediated repression.";
RL   Genes Dev. 14:55-66(2000).
RN   [3]
RP   INTERACTION WITH HDAC7, NUCLEAR EXPORT, AND MUTAGENESIS OF HIS-824 AND
RP   HIS-884.
RX   PubMed=10984530; DOI=10.1073/pnas.97.19.10330;
RA   Downes M., Ordentlich P., Kao H.-Y., Alvarez J.G.A., Evans R.M.;
RT   "Identification of a nuclear domain with deacetylase activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:10330-10335(2000).
RN   [4]
RP   INTERACTION WITH CTBP1 AND HDAC9.
RX   PubMed=11022042; DOI=10.1074/jbc.M007364200;
RA   Zhang C.L., McKinsey T.A., Lu J.R., Olson E.N.;
RT   "Association of COOH-terminal-binding protein (CtBP) and MEF2-
RT   interacting transcription repressor (MITR) contributes to
RT   transcriptional repression of the MEF2 transcription factor.";
RL   J. Biol. Chem. 276:35-39(2001).
RN   [5]
RP   INTERACTION WITH PHB2.
RX   PubMed=15140878; DOI=10.1074/jbc.M312300200;
RA   Kurtev V., Margueron R., Kroboth K., Ogris E., Cavailles V.,
RA   Seiser C.;
RT   "Transcriptional regulation by the repressor of estrogen receptor
RT   activity via recruitment of histone deacetylases.";
RL   J. Biol. Chem. 279:24834-24843(2004).
RN   [6]
RP   INTERACTION WITH NRIP1.
RX   PubMed=15060175; DOI=10.1093/nar/gkh524;
RA   Castet A., Boulahtouf A., Versini G., Bonnet S., Augereau P.,
RA   Vignon F., Khochbin S., Jalaguier S., Cavailles V.;
RT   "Multiple domains of the receptor-interacting protein 140 contribute
RT   to transcription inhibition.";
RL   Nucleic Acids Res. 32:1957-1966(2004).
RN   [7]
RP   INTERACTION WITH MYOCD.
RX   PubMed=15601857; DOI=10.1128/MCB.25.1.364-376.2005;
RA   Cao D., Wang Z., Zhang C.L., Oh J., Xing W., Li S., Richardson J.A.,
RA   Wang D.Z., Olson E.N.;
RT   "Modulation of smooth muscle gene expression by association of histone
RT   acetyltransferases and deacetylases with myocardin.";
RL   Mol. Cell. Biol. 25:364-376(2005).
RN   [8]
RP   PHOSPHORYLATION AT SER-250 AND SER-488, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF SER-250 AND SER-488.
RX   PubMed=17468767; DOI=10.1038/nm1573;
RA   Berdeaux R., Goebel N., Banaszynski L., Takemori H., Wandless T.,
RA   Shelton G.D., Montminy M.;
RT   "SIK1 is a class II HDAC kinase that promotes survival of skeletal
RT   myocytes.";
RL   Nat. Med. 13:597-603(2007).
RN   [9]
RP   INTERACTION WITH AHRR.
RX   PubMed=17949687; DOI=10.1016/j.bbrc.2007.09.131;
RA   Oshima M., Mimura J., Yamamoto M., Fujii-Kuriyama Y.;
RT   "Molecular mechanism of transcriptional repression of AhR repressor
RT   involving ANKRA2, HDAC4, and HDAC5.";
RL   Biochem. Biophys. Res. Commun. 364:276-282(2007).
RN   [10]
RP   INTERACTION WITH GRK5, AND PHOSPHORYLATION.
RX   PubMed=18711143; DOI=10.1073/pnas.0803153105;
RA   Martini J.S., Raake P., Vinge L.E., DeGeorge B.R. Jr., Chuprun J.K.,
RA   Harris D.M., Gao E., Eckhart A.D., Pitcher J.A., Koch W.J.;
RT   "Uncovering G protein-coupled receptor kinase-5 as a histone
RT   deacetylase kinase in the nucleus of cardiomyocytes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12457-12462(2008).
RN   [11]
RP   PHOSPHORYLATION AT SER-250 AND SER-488, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF SER-250 AND SER-488.
RX   PubMed=21454484; DOI=10.1074/jbc.M110.199372;
RA   Zhao J.X., Yue W.F., Zhu M.J., Du M.;
RT   "AMP-activated protein kinase regulates beta-catenin transcription via
RT   histone deacetylase 5.";
RL   J. Biol. Chem. 286:16426-16434(2011).
CC   -!- FUNCTION: Responsible for the deacetylation of lysine residues on
CC       the N-terminal part of the core histones (H2A, H2B, H3 and H4).
CC       Histone deacetylation gives a tag for epigenetic repression and
CC       plays an important role in transcriptional regulation, cell cycle
CC       progression and developmental events. Histone deacetylases act via
CC       the formation of large multiprotein complexes. Involved in muscle
CC       maturation by repressing transcription of myocyte enhancer MEF2C.
CC       During muscle differentiation, it shuttles into the cytoplasm,
CC       allowing the expression of myocyte enhancer factors (By
CC       similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of an N(6)-acetyl-lysine residue of
CC       a histone to yield a deacetylated histone.
CC   -!- SUBUNIT: Interacts with AHRR, BAHD1, BCOR, HDAC7, HDAC9, CTBP1,
CC       MEF2C, NCOR2, NRIP1, PHB2 and a 14-3-3 chaperone protein.
CC       Interacts with BCL6, DDIT3/CHOP, GRK5, KDM5B and MYOCD. Interacts
CC       with EP300 in the presence of TFAP2C.
CC       {ECO:0000269|PubMed:10640276, ECO:0000269|PubMed:10984530,
CC       ECO:0000269|PubMed:11022042, ECO:0000269|PubMed:15060175,
CC       ECO:0000269|PubMed:15140878, ECO:0000269|PubMed:15601857,
CC       ECO:0000269|PubMed:17949687, ECO:0000269|PubMed:18711143}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Shuttles between
CC       the nucleus and the cytoplasm. In muscle cells, it shuttles into
CC       the cytoplasm during myocyte differentiation. The export to
CC       cytoplasm depends on the interaction with a 14-3-3 chaperone
CC       protein and is due to its phosphorylation at Ser-250 and Ser-488
CC       by AMPK, CaMK1 and SIK1.
CC   -!- DOMAIN: The nuclear export sequence mediates the shuttling between
CC       the nucleus and the cytoplasm.
CC   -!- PTM: Phosphorylated by AMPK, CaMK1, SIK1 and PRKD1 at Ser-250 and
CC       Ser-488. The phosphorylation is required for the export to the
CC       cytoplasm and inhibition. Phosphorylated by the PKC kinases PKN1
CC       and PKN2, impairing nuclear import (By similarity). Phosphorylated
CC       by GRK5, leading to nuclear export of HDAC5 and allowing MEF2-
CC       mediated transcription. {ECO:0000250, ECO:0000269|PubMed:17468767,
CC       ECO:0000269|PubMed:18711143, ECO:0000269|PubMed:21454484}.
CC   -!- PTM: Ubiquitinated. Polyubiquitination however does not lead to
CC       its degradation (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the histone deacetylase family. HD type 2
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF006602; AAD09834.2; -; mRNA.
DR   EMBL; AF207748; AAF31418.1; -; mRNA.
DR   UniGene; Mm.22665; -.
DR   ProteinModelPortal; Q9Z2V6; -.
DR   SMR; Q9Z2V6; 68-132, 672-1052.
DR   DIP; DIP-40855N; -.
DR   IntAct; Q9Z2V6; 4.
DR   MINT; MINT-125422; -.
DR   BindingDB; Q9Z2V6; -.
DR   ChEMBL; CHEMBL2768; -.
DR   PhosphoSite; Q9Z2V6; -.
DR   MaxQB; Q9Z2V6; -.
DR   PaxDb; Q9Z2V6; -.
DR   PRIDE; Q9Z2V6; -.
DR   MGI; MGI:1333784; Hdac5.
DR   eggNOG; COG0123; -.
DR   HOVERGEN; HBG057100; -.
DR   InParanoid; Q9Z2V6; -.
DR   ChiTaRS; Hdac5; mouse.
DR   PRO; PR:Q9Z2V6; -.
DR   Proteomes; UP000000589; Unplaced.
DR   CleanEx; MM_HDAC5; -.
DR   Genevestigator; Q9Z2V6; -.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:MGI.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:MGI.
DR   GO; GO:0000118; C:histone deacetylase complex; TAS:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0001047; F:core promoter binding; ISO:MGI.
DR   GO; GO:0001046; F:core promoter sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0004407; F:histone deacetylase activity; TAS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC.
DR   GO; GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IEA:UniProtKB-EC.
DR   GO; GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IEA:UniProtKB-EC.
DR   GO; GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IEA:UniProtKB-EC.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0005080; F:protein kinase C binding; ISO:MGI.
DR   GO; GO:0070491; F:repressing transcription factor binding; ISO:MGI.
DR   GO; GO:0001077; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; IMP:UniProtKB.
DR   GO; GO:0001085; F:RNA polymerase II transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:MGI.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0042113; P:B cell activation; TAS:UniProtKB.
DR   GO; GO:0030183; P:B cell differentiation; TAS:UniProtKB.
DR   GO; GO:0071498; P:cellular response to fluid shear stress; IDA:UniProtKB.
DR   GO; GO:0016568; P:chromatin modification; TAS:UniProtKB.
DR   GO; GO:0007507; P:heart development; IGI:MGI.
DR   GO; GO:0016575; P:histone deacetylation; ISO:MGI.
DR   GO; GO:0006954; P:inflammatory response; TAS:UniProtKB.
DR   GO; GO:0033555; P:multicellular organismal response to stress; IMP:MGI.
DR   GO; GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; ISO:MGI.
DR   GO; GO:0010832; P:negative regulation of myotube differentiation; ISO:MGI.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; IMP:MGI.
DR   GO; GO:0045843; P:negative regulation of striated muscle tissue development; TAS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; TAS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; TAS:UniProtKB.
DR   GO; GO:0002076; P:osteoblast development; IMP:MGI.
DR   GO; GO:2000179; P:positive regulation of neural precursor cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; ISO:MGI.
DR   GO; GO:2000648; P:positive regulation of stem cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:0040029; P:regulation of gene expression, epigenetic; ISO:MGI.
DR   GO; GO:0010830; P:regulation of myotube differentiation; IDA:UniProtKB.
DR   GO; GO:0043393; P:regulation of protein binding; ISO:MGI.
DR   GO; GO:0048742; P:regulation of skeletal muscle fiber development; IGI:MGI.
DR   GO; GO:0051153; P:regulation of striated muscle cell differentiation; IGI:MGI.
DR   GO; GO:0061333; P:renal tubule morphogenesis; IMP:UniProtKB.
DR   GO; GO:0042220; P:response to cocaine; IDA:MGI.
DR   Gene3D; 3.40.800.20; -; 1.
DR   InterPro; IPR000286; His_deacetylse.
DR   InterPro; IPR023801; His_deacetylse_dom.
DR   InterPro; IPR024643; Hist_deacetylase_Gln_rich_N.
DR   InterPro; IPR017320; Histone_deAcase_II_euk.
DR   PANTHER; PTHR10625; PTHR10625; 1.
DR   Pfam; PF12203; HDAC4_Gln; 1.
DR   Pfam; PF00850; Hist_deacetyl; 1.
DR   PIRSF; PIRSF037911; HDAC_II_euk; 1.
DR   PRINTS; PR01270; HDASUPER.
PE   1: Evidence at protein level;
KW   Acetylation; Chromatin regulator; Complete proteome; Cytoplasm;
KW   Hydrolase; Metal-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Repressor; Transcription; Transcription regulation; Ubl conjugation;
KW   Zinc.
FT   CHAIN         1   1113       Histone deacetylase 5.
FT                                /FTId=PRO_0000114702.
FT   REGION      675   1019       Histone deacetylase.
FT   MOTIF      1072   1113       Nuclear export signal. {ECO:0000250}.
FT   COMPBIAS     47     52       Poly-Gly.
FT   COMPBIAS     85     92       Poly-Gln.
FT   COMPBIAS    577    588       Poly-Glu.
FT   ACT_SITE    824    824       {ECO:0000250}.
FT   METAL       687    687       Zinc. {ECO:0000250}.
FT   METAL       689    689       Zinc. {ECO:0000250}.
FT   METAL       695    695       Zinc. {ECO:0000250}.
FT   METAL       772    772       Zinc. {ECO:0000250}.
FT   MOD_RES     250    250       Phosphoserine; by AMPK, CaMK1, SIK1 and
FT                                PKD/PRKD1. {ECO:0000269|PubMed:17468767,
FT                                ECO:0000269|PubMed:21454484}.
FT   MOD_RES     283    283       Phosphothreonine; by PKC. {ECO:0000250}.
FT   MOD_RES     488    488       Phosphoserine; by AMPK, CaMK1, SIK1 and
FT                                PKD/PRKD1. {ECO:0000269|PubMed:17468767,
FT                                ECO:0000269|PubMed:21454484}.
FT   MOD_RES     523    523       N6-acetyllysine. {ECO:0000250}.
FT   MOD_RES     650    650       Phosphoserine. {ECO:0000250}.
FT   MUTAGEN     250    250       S->A: Abolishes phosphorylation by SIK1
FT                                and fails to promote beta-catenin
FT                                expression; when associated with A-488.
FT                                {ECO:0000269|PubMed:17468767,
FT                                ECO:0000269|PubMed:21454484}.
FT   MUTAGEN     488    488       S->A: Abolishes phosphorylation by SIK1
FT                                and fails to promote beta-catenin
FT                                expression; when associated with A-250.
FT                                {ECO:0000269|PubMed:17468767,
FT                                ECO:0000269|PubMed:21454484}.
FT   MUTAGEN     824    824       H->A: Abolishes deacetylase activity.
FT                                {ECO:0000269|PubMed:10984530}.
FT   MUTAGEN     884    884       H->F: Disrupts the dot-like nuclear
FT                                pattern. {ECO:0000269|PubMed:10984530}.
FT   CONFLICT      7      7       S -> SA (in Ref. 2; AAF31418).
FT                                {ECO:0000305}.
FT   CONFLICT     18     18       G -> E (in Ref. 2; AAF31418).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1113 AA;  120942 MW;  63071AF45B87815A CRC64;
     MNSPNESDGM SGREPSLGIL PRTPLHSIPV AVEVKPVLPG AMPSSMGGGG GGSPSPVELR
     GALAGPMDPA LREQQLQQEL LVLKQQQQLQ KQLLFAEFQK QHDHLTRQHE VQLQKHLKQQ
     QEMLAAKRQQ ELEQQRQREQ QRQEELEKQR LEQQLLILRN KEKSKESAIA STEVKLRLQE
     FLLSKSKEPT PGGLNHSLPQ HPKCWGAHHA SLDQSSPPQS GPPGTPPSYK LPLLGPYDSR
     DDFPLRKTAS EPNLKVRSRL KQKVAERRSS PLLRRKDGTV ISTFKKRAVE ITGTGPGVSS
     VCNSAPGSGP SSPNSSHSTI AENGFTGSVP NIPTEMIPQH RALPLDSSPN QFSLYTSPSL
     PNISLGLQAT VTVTNSHLTA SPKLSTQQEA ERQALQSLRQ GGTLTGKFMS TSSIPGCLLG
     VALEGDTSPH GHASLLQHVC SWTGRQQSTL IAVPLHGQSP LVTGERVATS MRTVGKLPRH
     RPLSRTQSSP LPQSPQALQQ LVMQQQHQQF LEKQKQQQMQ LGKILTKTGE LSRQPTTHPE
     ETEEELTEQQ EALLGEGALT IPREGSTESE STQEDLEEEE EEEEEEEEDC IQVKDEDGES
     GPDEGPDLEE SSAGYKKLFA DAQQLQPLQV YQAPLSLATV PHQALGRTQS SPAAPGSMKS
     PTDQPTVVKH LFTTGVVYDT FMLKHQCMCG NTHVHPEHAG RIQSIWSRLQ ETGLLGKCER
     IRGRKATLDE IQTVHSEYHT LLYGTSPLNR QKLDSKKLLG PISQKMYAML PCGGIGVDSD
     TVWNEMHSSS AVRMAVGCLV ELAFKVAAGE LKNGFAIIRP PGHHAEESTA MGFCFFNSVA
     ITAKLLQQKL SVGKVLIVDW DIHHGNGTQQ AFYNDPSVLY ISLHRYDNGN FFPGSGAPEE
     VGGGPGVGYN VNVAWTGGVD PPIGDVEYLT AFRTVVMPIA QEFSPDVVLV SAGFDAVEGH
     LSPLGGYSVT ARCFGHLTRQ LMTLAGGRVV LALEGGHDLT AICDASEACV SALLSVELQP
     LDEAVLQQKP SVNAVATLEK VIEIQSKHWS CVQRFAAGLG CSLREAQTGE KEEAETVSAM
     ALLSVGAEQA QAVATQEHSP RPAEEPMEQE PAL
//
